---
figid: PMC5835847__ol-15-04-4061-g00
figtitle: LEF1 in the Notch signaling pathway
organisms:
- NA
pmcid: PMC5835847
filename: ol-15-04-4061-g00.jpg
figlink: /pmc/articles/PMC5835847/figure/f1-ol-0-0-7854/
number: F1
caption: The hypothetic mechanism of LEF1 in the Notch signaling pathway. In the nucleus,
  PML/RARα fusion gene may induce plakoglobin (γ-catenin) expression, leading to transcriptional
  activation of LEF1. LEF1 itself is a coactivator of NICD and may crosstalk with
  the Notch signaling pathway by regulating the expression of JAG1 on the cytomembrane.
  Furthermore, JAG1 is overexpressed in APL, and upon receiving ATRA therapy, it is
  downregulated in the NB4 cell line which indicates that JAG1 may be a therapeutic
  target of ATRA. PML, promyelocytic leukemia; RARα retinoic acid receptor α; LEF1,
  lymphoid enhancer binding factor-1; NICD, Notch intracellular domain; APL, acute
  promyelocytic leukemia; ATRA, all-trans retinoic acid; JAG1, Jagged 1.
papertitle: 'Early mortality in acute promyelocytic leukemia: Potential predictors.'
reftext: Can Chen, et al. Oncol Lett. 2018 Apr;15(4):4061-4069.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9221775
figid_alias: PMC5835847__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5835847__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5835847__ol-15-04-4061-g00.html
  '@type': Dataset
  description: The hypothetic mechanism of LEF1 in the Notch signaling pathway. In
    the nucleus, PML/RARα fusion gene may induce plakoglobin (γ-catenin) expression,
    leading to transcriptional activation of LEF1. LEF1 itself is a coactivator of
    NICD and may crosstalk with the Notch signaling pathway by regulating the expression
    of JAG1 on the cytomembrane. Furthermore, JAG1 is overexpressed in APL, and upon
    receiving ATRA therapy, it is downregulated in the NB4 cell line which indicates
    that JAG1 may be a therapeutic target of ATRA. PML, promyelocytic leukemia; RARα
    retinoic acid receptor α; LEF1, lymphoid enhancer binding factor-1; NICD, Notch
    intracellular domain; APL, acute promyelocytic leukemia; ATRA, all-trans retinoic
    acid; JAG1, Jagged 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - PML
  - RARA
  - ATRA
---
